Big Trouble for Biglari Under the HSR Act – and Why Cannabis Operators Should Take Note
March 2, 2022
By: Lisl Dunlop and Sam Sherman
Cannabis Business Executive
Axinn partner Lisl Dunlop and associate Sam Sherman co-authored the Cannabis Business Executive article, "Big Trouble for Biglari Under the HSR Act – and Why Cannabis Operators Should Take Note."
Click here to access the article.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
IBA Annual Conference 2025
Speaking Engagement
Antitrust
GCR Live: Global Merger Control 2025
Speaking Engagement
Antitrust
Thomson Reuters 24th Annual Law Firm COO & CFO Forum
Speaking Engagement
LegalNEXT 2025
Speaking Engagement
Antitrust
Informa Antitrust Texas 2025
Speaking Engagement
Antitrust
ACI Forum on Pharma & Biotech Patent Litigation USA 2025
Speaking Engagement
Intellectual Property
MCCA Gala 2025
Sponsorship
Antitrust
In Fashion, One Day You’re In and the Next Day You’re Out (Of Chances to Plead Violations of the Sherman Act)
Axinn Viewpoints
Antitrust
Axinn Honored at the 2025 Transform Awards North America
Awards & Recognitions
Antitrust 101: Trial-Minded Antitrust Discovery
Webinar
Antitrust